GlassScriptPhysician profile
Delshad Ahmad
NPI 1043508666
$781.89
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $532 · 2021: $50.58 · 2023: $70.70 · 2024: $129.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $179 · Education: $19.81.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $179.49 |
| Education | $19.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $158.90 | 2019 | |
| Tempus Ai, INC | $128.60 | 2024 | |
| Genentech USA, INC. | $60.34 | 2019 | |
| Merck Sharp & Dohme LLC | $51.76 | 2019-2023 | Keytruda |
| Abbvie INC. | $50.58 | 2021 | |
| Foundation Medicine, INC. | $32.92 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $31.34 | 2019 | |
| Menarini Silicon Biosystems, INC. | $30.02 | 2023 | Cellsearch |
| Pharmacyclics LLC, An Abbvie Company | $29.89 | 2019 | |
| Dendreon Pharmaceuticals LLC | $29.53 | 2019 | |
| Janssen Scientific Affairs, LLC | $29.29 | 2019 | |
| Emd Serono, INC. | $23.35 | 2019 | |
| Genzyme Corporation | $20.87 | 2023 | |
| Clovis Oncology, INC. | $19.08 | 2019 | |
| Rigel Pharmaceuticals, INC. | $18.19 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $16.80 | 2019 | |
| Janssen Biotech, INC. | $14.23 | 2019 | |
| Daiichi Sankyo INC. | $12.54 | 2019 | |
| Pfizer INC. | $11.96 | 2019 | |
| Puma Biotechnology, INC. | $11.70 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Delshad Ahmad listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.